Pacific Biosciences Of California (PACB) Revenue Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 0.73% |
| 10 | Pacific Biosciences Of California | 414.38 Mn | 138.42 Mn | 12.84 Mn | -1.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50% |
| Dec 31, 2025 | 17.74% |
| Sep 30, 2025 | 5.96% |
| Jun 30, 2025 | 3.89% |
| Mar 31, 2025 | 3.85% |
| Dec 31, 2024 | 2.88% |
| Jun 30, 2024 | 5.57% |
| Mar 31, 2024 | 10.20% |
| Dec 31, 2023 | 29.08% |
| Sep 30, 2023 | 42.91% |
| Jun 30, 2023 | 40.71% |
| Mar 31, 2023 | 35.61% |
| Dec 31, 2022 | -0.69% |
| Sep 30, 2022 | 13.82% |
| Jun 30, 2022 | 12.94% |
| Mar 31, 2022 | 26.40% |
| Dec 31, 2021 | 22.64% |
| Jun 30, 2021 | 12.36% |
| Mar 31, 2021 | 14.41% |
| Dec 31, 2020 | 2.86% |